2025
The association between clinical trial participation, drug costs, and performance in the Oncology Care Model
Canavan M, Westvold S, Csik V, Franks J, Rocque G, Gross C, Adelson K. The association between clinical trial participation, drug costs, and performance in the Oncology Care Model. Journal Of The National Cancer Institute 2025, djaf008. PMID: 39842859, DOI: 10.1093/jnci/djaf008.Peer-Reviewed Original ResearchThis study investigates how clinical trial participation in the Oncology Care Model affects drug costs and performance, showing potential advantages for academic centers in value-based programs.
2024
Why do we need quality measures in emergency medicine?
Das S, Miller G, Libby C, Gettel C, Rabin E, Lin M. Why do we need quality measures in emergency medicine? Journal Of The American College Of Emergency Physicians Open 2024, 5: e13329. PMID: 39697807, PMCID: PMC11652395, DOI: 10.1002/emp2.13329.Peer-Reviewed Original ResearchMerit-based incentive payment systemEmergency physiciansEmergency careQuality measuresPatient safety committeeImprove care deliveryAlternative payment modelsPracticing emergency physiciansReimbursement of careCenters for MedicareIncentive Payment SystemMeasure development processPhysician qualityCare deliveryEmergency medicineHealthcare servicesPayment modelsImpact reimbursementEmergency departmentAmerican CollegeCarePhysiciansReimbursementSafety CommitteePayment systemAlternative Payment Models and Performance in Federally Qualified Health Centers
Markowski J, Wallace J, Schlesinger M, Ndumele C. Alternative Payment Models and Performance in Federally Qualified Health Centers. JAMA Internal Medicine 2024, 184: 1065-1073. PMID: 38976258, PMCID: PMC11231906, DOI: 10.1001/jamainternmed.2024.2754.Peer-Reviewed Original ResearchPayment modelsMeasures of health care qualityPayer mixFederally Qualified Health CentersCohort studyValue-based payment modelsHealth care safety netColorectal cancer screeningHealth promotion modelHealth care qualityQualified health centersUniform Data SystemHealth outcome measuresAlternative payment modelsRisk profileFQHC patientsAssociated with clinicCare qualityChild BMIAdult BMICancer screeningState Medicaid programsIncentivizing qualityHealth centersRetrospective cohort study
2022
Drivers of Medicare Spending: A 20-Year Review of Radiation Oncology Charges Allowed per Person as Compared to Other Specialties
Mokhtech M, Laird J, Maroongroge S, Johnstone P, Mantz C, Ennis R, Sandler H, Falit B, Dosoretz A, Yu J. Drivers of Medicare Spending: A 20-Year Review of Radiation Oncology Charges Allowed per Person as Compared to Other Specialties. International Journal Of Radiation Oncology • Biology • Physics 2022, 114: s102. DOI: 10.1016/j.ijrobp.2022.07.526.Peer-Reviewed Original ResearchMedicare Part B enrolleesAlternative payment modelsPhysician chargesConsumer price indexPayment modelsPrice indexExpenditure growthRadiation oncologyProgram paymentsHealth care providersLabor StatisticsInflationMedicare spendingHematology-OncologyMedical oncologyUS BureauPhysician specialtyCare providersMedicare feeMedicare beneficiariesMedical careMedicare expendituresOncology modelsPURPOSE/Beneficiary care
2020
The association between clinical trial (CT) participation, pharmaceutical costs, and savings performance in the Oncology Care Model (OCM).
Adelson K, Canavan M, Mun S, Gross C, Sinanis N, Davidoff A. The association between clinical trial (CT) participation, pharmaceutical costs, and savings performance in the Oncology Care Model (OCM). Journal Of Clinical Oncology 2020, 38: 2-2. DOI: 10.1200/jco.2020.38.29_suppl.2.Peer-Reviewed Original ResearchOncology Care ModelDrug costsCancer CenterLung cancerEpisode costsMean MedicareYale Cancer CenterClinical trial participationSystemic cancer therapyPart D drug costsCancer therapyLower drug costsCommon cancer typesChi-square testPayment modelsClinical factorsNovel cancer therapiesTrial participationOvarian cancerPatient episodesNovel therapiesCare modelCTR groupPharmaceutical costsAlternative payment modelsThe impact of clinical trial (CTr) participation on savings performance in the oncology care model (OCM).
Adelson K, Canavan M, Mun S, Gross C, Sinanis N, Davidoff A. The impact of clinical trial (CTr) participation on savings performance in the oncology care model (OCM). Journal Of Clinical Oncology 2020, 38: e19367-e19367. DOI: 10.1200/jco.2020.38.15_suppl.e19367.Peer-Reviewed Original ResearchOncology Care ModelDrug costsMean MedicareYale Cancer CenterMean drug costClinical trial participationSystemic cancer therapyLower drug costsCommon cancer typesChi-square testValue-based payment modelsPayment modelsClinical factorsCancer CenterTrial participationLung cancerEpisode costsCare modelCTR groupAlternative payment modelsCancer typesMean differenceCancer therapyCareEpisodes
2019
Simulated Costs of the ASCO Patient-Centered Oncology Payment Model in Medicare Beneficiaries With Newly Diagnosed Advanced Ovarian Cancer.
Moss HA, Havrilesky LJ, Wang FF, Georgieva MV, Hendrix LH, Dinan MA. Simulated Costs of the ASCO Patient-Centered Oncology Payment Model in Medicare Beneficiaries With Newly Diagnosed Advanced Ovarian Cancer. JCO Oncology Practice 2019, 15: e1018-e1027. PMID: 31613721, PMCID: PMC10445789, DOI: 10.1200/jop.19.00026.Peer-Reviewed Original ResearchConceptsAdvanced ovarian cancerOvarian cancerAlternative payment modelsNeoadjuvant chemotherapy patientsEmergency department visitsSEER-Medicare dataMean total costOutpatient emergency department visitsPayment modelsHealth care servicesCost-efficient careAvoidable spendingNeoadjuvant chemotherapyReal-world practiceDepartment visitsChemotherapy patientsCancer careMedicare beneficiariesHospitalizationCare servicesPatientsService MedicareChemotherapySurgeryPotential cost savings
2017
Future considerations for clinical dermatology in the setting of 21st century American policy reform: The Medicare Access and Children's Health Insurance Program Reauthorization Act and Alternative Payment Models in dermatology
Barbieri JS, Miller JJ, Nguyen HP, Forman HP, Bolognia JL, VanBeek MJ, Dermatology F. Future considerations for clinical dermatology in the setting of 21st century American policy reform: The Medicare Access and Children's Health Insurance Program Reauthorization Act and Alternative Payment Models in dermatology. Journal Of The American Academy Of Dermatology 2017, 76: 1213-1217. PMID: 28365040, DOI: 10.1016/j.jaad.2017.01.031.Peer-Reviewed Original ResearchConceptsChildren's Health Insurance Program Reauthorization ActAlternative payment modelsPayment systemMedicare AccessIncentive Payment SystemNew alternative payment modelsPayment modelsCentury American policy reformReauthorization ActAccountable care organizationsPolicy reformsFinancial incentivesNew reimbursement modelsReimbursement modelsCare organizationsIncentivesPaymentsReformExemptionAccessModelActsIntroductionOrganizationCreation
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply